Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews

No studies found 4 · 66.7%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 33.3%Moderate 0 · 0%High 0 · 0%

Quality of life · patients with uterine fibroids

The review found no eligible studies for this question.

1 finding from 1 review

Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bone density (SMD) ‐ · patients with uterine fibroids

1 finding from 1 review

Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 95 participants
Low

Uterine size (cm3) ‐ · patients with uterine fibroids

The review found no eligible studies for this question.

1 finding from 1 review

Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Uterine bleeding · patients with uterine fibroids

The review found no eligible studies for this question.

1 finding from 1 review

Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Severity of vasomotor symptoms · patients with uterine fibroids

The review found no eligible studies for this question.

1 finding from 1 review

Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Rate of vasomotor symptoms ‐ · patients with uterine fibroids

GnRH‐a + ipriflavone showed no clear difference in rate of vasomotor symptoms ‐ compared with gnRH‐a ± placebo (low certainty).

1 finding from 1 review

Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
RR 0.67 [0.44, 1.02]
1 study · 95 participants
Low